Brief: Besunyen Holdings Co says unit acquires 20% equity interest in Runliang Pharmaceutical

Besunyen Holdings

02/09/2016 12:54

Sept 2 (Reuters) - Besunyen Holdings Co Ltd  0926.HK : 
 * Connected transaction in relation to acquisition of 20% equity interest in  Runliang Pharmaceutical  0926.HK  
 * Unit Beijing outsell, entered into equity transfer agreement with Tianrun Diliang 
 * Beijing outsell agreed to acquire 20% equity interest in Runliang   Pharmaceutical held by Tianrun Diliang at RMB10 million 
 * Beijing outsell agreed to acquire the 20% equity interest in Runliang Pharmaceutical held by Tianrun Diliang 
 
 * Source text for Eikon  ID:nHKS8hJfzV  
 
 * ((Further company coverage:  0926.HK )) 
   ((Bangalore.newsroom@thomsonreuters.com))